Based on the Teladoc Inc stock forecast from 0 analysts, the average analyst target price for Teladoc Inc is not available over the next 12 months. Teladoc Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Teladoc Inc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Teladoc Inc’s stock price was EUR 9.07. Teladoc Inc’s stock price has changed by -2.83% over the past week, -21.54% over the past month and -52.77% over the last year.
No recent analyst target price found for Teladoc Inc
No recent average analyst rating found for Teladoc Inc
Company Overview Teladoc Inc
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York. Read Less
Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chr...Read More
Frequently Asked Questions About Teladoc Inc (4LL:F) Stock
Stock Target Advisor's fundamental analysis for Teladoc Inc's stock is Neutral.
Unfortunately we do not have enough data on 4LL:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4LL:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4LL:F's stock to indicate if its overvalued.
The last closing price of 4LL:F's stock was EUR 9.07.
The most recent market capitalization for 4LL:F is EUR 1.84B.
Unfortunately we do not have enough analyst data on 4LL:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Teladoc Inc's stock.
As per our most recent records Teladoc Inc has 4,816 Employees.
Teladoc Inc's registered address is 2 Manhattanville Road, Purchase, NY, United States, 10577.
You can get more information about it from Teladoc Inc's website at https://www.teladochealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Teladoc Inc (4LL:F) Stock
Stock Target Advisor's fundamental analysis for Teladoc Inc's stock is Neutral.
Unfortunately we do not have enough data on 4LL:F's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4LL:F's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4LL:F's stock to indicate if its overvalued.
The last closing price of 4LL:F's stock was EUR 9.07.
The most recent market capitalization for 4LL:F is EUR 1.84B.
Unfortunately we do not have enough analyst data on 4LL:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Teladoc Inc's stock.
As per our most recent records Teladoc Inc has 4,816 Employees.
Teladoc Inc's registered address is 2 Manhattanville Road, Purchase, NY, United States, 10577.
You can get more information about it from Teladoc Inc's website at https://www.teladochealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4LL:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
